Gain Therapeutics (GANX) FCF Margin (2020 - 2023)
Gain Therapeutics (GANX) posted quarterly FCF Margin of 7663.03% for Q1 2023, down 220772.0% year-over-year from N/an in Q1 2022, and down 114.1% quarter-over-quarter from 54363.48% in Q4 2022.
Gain Therapeutics (GANX) FCF Margin (2020 - 2023) Analysis & Trends
Gain Therapeutics' FCF Margin history runs 4 years deep, the most recent figure standing at 7663.03% for Q1 2023.
- In Q1 2023, FCF Margin fell 220772.0% year-over-year to 7663.03%; the TTM figure through Dec 2023 stood at 34217.53% (down 2313864.0% YoY), while the FY2023 annual figure was 34217.53%, down 2313864.0% from the prior year.
- FCF Margin for Q1 2023 stood at 7663.03%, down from 54363.48% in the prior quarter.
- The five-year high for FCF Margin was 54363.48% in Q4 2022, with the low at 53869.71% in Q1 2021.
- The 4-year median for FCF Margin is 8423.41% (2021), against an average of 8881.89%.
- The sharpest annual moves came in 2021 and 2022: FCF Margin sank 4251480 bps in 2021, then jumped 8518565 bps in 2022.
- Gain Therapeutics' FCF Margin stood at 14641.7% in 2020, then tumbled by 111 bps to 30822.16% in 2021, then jumped by 276 bps to 54363.48% in 2022, then sank by 114 bps to 7663.03% in 2023.
- Business Quant data shows GANX's FCF Margin at 7663.03% in Q1 2023, 54363.48% in Q4 2022, and 5358.05% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 70.82% |
| 10 | Gain Therapeutics | 87.51 Mn | 87.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -7,663.03% |
| Dec 31, 2022 | 54,363.48% |
| Jun 30, 2022 | -5,358.05% |
| Mar 31, 2022 | -5,455.31% |
| Dec 31, 2021 | -30,822.16% |
| Sep 30, 2021 | -9,183.78% |
| Jun 30, 2021 | -4,243.15% |
| Mar 31, 2021 | -53,869.71% |
| Dec 31, 2020 | -14,641.70% |
| Sep 30, 2020 | -11,699.01% |
| Jun 30, 2020 | -6,655.39% |
| Mar 31, 2020 | -11,354.91% |